Insulin-independent reversal of type 1 diabetes in nonobese diabetic mice with brown adipose tissue transplant

American Journal of Physiology - Endocrinology and Metabolism

Volumn 308, Issue 12, 2015, Pages E1043-E1055

  Gunawardana, Subhadra C ^a   Piston, David W ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brown adipose tissue; Insulin independent; Insulin like growth factor I; Transplantation; Type 1 diabetes

Indexed keywords

ADIPOCYTOKINE; GLUCAGON; GLUCOSE; GROWTH HORMONE; INSULIN; INSULIN RECEPTOR; SOMATOMEDIN C; GLUCOSE BLOOD LEVEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; BROWN ADIPOSE TISSUE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETES CONTROL; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; GLYCEMIC CONTROL; GRAFT RECIPIENT; GROWTH HORMONE BLOOD LEVEL; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLIC PARAMETERS; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TISSUE REGENERATION; TISSUE TRANSPLANTATION; WHITE ADIPOSE TISSUE; ANIMAL; ANIMAL EMBRYO; C57BL MOUSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; EMBRYOLOGY; FETAL TISSUE TRANSPLANTATION; INSULIN RESISTANCE; METABOLISM; PREGNANCY; TRANSPLANTATION;

ADIPOSE TISSUE, BROWN; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; EMBRYO, MAMMALIAN; FEMALE; FETAL TISSUE TRANSPLANTATION; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; PREGNANCY;

EID: 84931045954     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00570.2014     Document Type: Article

References (82)

1. Acerini CL, Patton CM, Savage MO, Kernell A, Westphal O, Dunger DB. Randomised placebo-controlled trial of human recombinant insulinlike growth factor I plus intensive insulin therapy in adolescents with insulin-dependent diabetes mellitus. Lancet 350: 1199–1204, 1997.
2. Attie AD, Scherer PE. Adipocyte metabolism and obesity. J Lipid Res 50 Suppl: S395–S399, 2009.
3. Ayala JE, Bracy DP, McGuinness OP, Wasserman DH. Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse. Diabetes 55: 390–397, 2006.
4. Aydin F, Kaya A, Karapinar L, Kumbaraci M, Imerci A, Karapinar H, Karakuzu C, Incesu M. IGF-1 Increases with Hyperbaric Oxygen Therapy and Promotes Wound Healing in Diabetic Foot Ulcers. J Diabetes Res 2013: 567834, 2013.
5. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Review Circ Res 96: 939–949, 2005.
6. Berglund ED, Li CY, Poffenberger G, Ayala JE, Fueger PT, Willis SE, Jewell MM, Powers AC, Wasserman DH. Glucose metabolism in vivo in four commonly used inbred mouse strains. Diabetes 57: 1790–1799, 2008.
7. Carlton ED, Demas GE, French SS. Leptin, a neuroendocrine mediator of immune responses, inflammation, and sickness behaviors. Horm Behav 62: 272–279, 2012.
8. Clemmons DR. Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes. Endocrinol Metab Clin North Am 41: 425–443, 2012.
9. Copland JA, Pardini AW, Wood TG, Yin D, Green A, Bodenburg YH, Urban RJ, Stuart CA. IGF-1 controls GLUT3 expression in muscle via the transcriptional factor Sp1. Biochim Biophys Acta 1769: 631-640, 2007.
10. Cypess AM, Kahn CR. Brown fat as a therapy for obesity and diabetes. Curr Opin Endocrinol Diabetes Obes 17: 143-149, 2010.
11. Duncan BB, Schmidt MI. The epidemiology of low-grade chronic systemic inflammation and type 2 diabetes. Diabetes Technol Ther 8: 7-17, 2006.
12. Emmerson E, Campbell L, Davies FC, Ross NL, Ashcroft GS, Krust A, Chambon P, Hardman MJ. Insulin-like growth factor-1 promotes wound healing in estrogen-deprived mice: new insights into cutaneous IGF-1R/ERa cross talk. J Invest Dermatol 132: 2838-2848, 2012.
13. Erbagci AB, Tarakçioglu M, Coskun Y, Sivasli E, Sibel Namiduru E. Mediators of inflammation in children with type I diabetes mellitus: cytokines in type I diabetic children. Clin Biochem 34: 645-650, 2001.
14. Falcão-Pires I, Castro-Chaves P, Miranda-Silva D, Lourenço AP, Leite-Moreira AF. Physiological, pathological and potential therapeutic roles of adipokines. Drug Discov Today 17: 880-889, 2012.
15. Fladeby C, Skar R, Serck-Hanssen G. Distinct regulation of glucose transport and GLUT1/GLUT3 transporters by glucose deprivation and IGF-I in chromaffin cells. Biochim Biophys Acta 1593: 201-208, 2003.
16. Fischer-Posovszky P, Wang QA, Asterholm IW, Rutkowski JM, Scherer PE. Targeted deletion of adipocytes by apoptosis leads to adipose tissue recruitment of alternatively activated M2 macrophages. Endocrinology 152: 3074-3081, 2011.
17. Fisher G, Hyatt TC, Hunter GR, Oster RA, Desmond RA, Gower BA. Markers of inflammation and fat distribution following weight loss in African-American and white women. Obesity (Silver Spring) 20: 715-720, 2012.
18. Fujisaka S, Usui I, Bukhari A, Ikutani M, Oya T, Kanatani Y, Tsuneyama K, Nagai Y, Takatsu K, Urakaze M, Kobayashi M, Tobe K. Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes 58: 2574-2582, 2009.
19. Fukushima M, Hattori Y, Tsukada H, Koga K, Kajiwara E, Kawano K, Kobayashi T, Kamata K, Maitani Y. Adiponectin gene therapy of streptozotocin-induced diabetic mice using hydrodynamic injection. J Gene Med 9: 976-985, 2007.
20. Gannon MC, Nuttall FQ. Effect of a high-protein diet on ghrelin, growth hormone, and insulin-like growth factor-I and binding proteins 1 and 3 in subjects with type 2 diabetes mellitus. Metabolism 60: 1300-1311, 2011.
21. Ghosh MC, Gorantla V, Makena PS, Luellen C, Sinclair SE, Schwing-shackl A, Waters CM. Insulin-like growth factor-I stimulates differentiation of ATII cells to ATI-like cells through activation of Wnt5a. Am J Physiol Lung Cell Mol Physiol 305: L222-L228, 2013.
22. Ginter E, Simko V. Brown fat tissue - a potential target to combat obesity. Bratisl Lek Listy 113: 52-56, 2012.
23. Gómez-Hernández A, Otero YF, de las Heras N, Escribano O, Ca-chofeiro V, Lahera V, Benito M. Brown fat lipoatrophy and increased visceral adiposity through a concerted adipocytokines overexpression induces vascular insulin resistance and dysfunction. Endocrinology 153: 1242-1255, 2012.
24. Grohmann M, Sabin M, Holly J, Shield J, Crowne E, Stewart C. Characterization of differentiated subcutaneous and visceral adipose tissue from children: the influences of TNF-alpha and IGF-I. J Lipid Res 46: 93-103, 2005.
25. Grossman EJ, Lee DD, Tao J, Wilson RA, Park SY, Bell GI, Chong AS. Glycemic control promotes pancreatic beta-cell regeneration in streptozotocin-induced diabetic mice. PLoS One 5: e8749, 2010.
26. Gunawardana SC. Adipose tissue, hormones and treatment of type 1 diabetes. Curr Diab Rep 12: 542-550, 2012.
27. Gunawardana SC, Piston DW. Reversal of type 1 diabetes in mice by brown adipose tissue transplant. Diabetes 61: 674-682, 2012.
28. Gunawardana SC, Piston DW. Insulin-independent reversal of type-1 diabetes with brown adipose tissue transplants: Involvement of IGF-1 (Abstract). International Pancreas and Islet Transplant Association, 14th World Congress 244, 2013.
29. Hansen BF, Glendorf T, Hegelund AC, Lundby A, Lützen A, Slaaby R, Stidsen CE. Molecular characterisation of long-acting insulin analogues in comparison with human insulin, IGF-1 and insulin X10. PLoS One 7: e34274, 2012.
30. Holly J, Sabin M, Perks C, Shield J. Adipogenesis and IGF-1. Metab Syndr Relat Disord 4: 43-50, 2006.
31. Hu X, She M, Hou H, Li Q, Shen Q, Luo Y, Yin W. Adiponectin decreases plasma glucose and improves insulin sensitivity in diabetic swine. Acta Biochim Biophys Sin (Shanghai) 39: 131–136, 2007.
32. Jin E, Kim JM, Kim SW. Priming of mononuclear cells with a combination of growth factors enhances wound healing via high angiogenic and engraftment capabilities. J Cell Mol Med 17: 1644–1651, 2013.
33. Kandasamy AD, Sung MM, Boisvenue JJ, Barr AJ, Dyck JR. Adi-ponectin gene therapy ameliorates high-fat, high-sucrose diet-induced metabolic perturbations in mice. Nutr Diabetes 2: e45, 2012.
34. Kim S, Jin Y, Choi Y, Park T. Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice. Biochem Pharmacol 81: 1343–1351, 2011.
35. Kraegen EW, Jenkins AB, Storlien LH, Chisholm DJ. Tracer studies of in vivo insulin action and glucose metabolism in individual peripheral tissues. Horm Metab Res Suppl 24: 41–48, 1990.
36. Kruger AJ, Yang C, Lipson KL, Pino SC, Leif JH, Hogan CM, Whalen BJ, Guberski DL, Lee Y, Unger RH, Greiner DL, Rossini AA, Bortell R. Leptin treatment confers clinical benefit at multiple stages of virally induced type 1 diabetes in BB rats. Autoimmunity 44: 137–148, 2011.
37. Lee H, Lee IS, Choue R. Obesity, inflammation and diet. Pediatr Gastroenterol Hepatol Nutr 16: 143–152, 2013.
38. LeRoith D, Yakar S. Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1. Nat Clin Pract Endocrinol Metab 3: 302–310, 2007.
39. Li Y, Shelat H, Geng YJ. IGF-1 prevents oxidative stress induced-apoptosis in induced pluripotent stem cells which is mediated by mi-croRNA-1. Biochem Biophys Res Commun 426: 615–619, 2012.
40. Li L, Wu LL. Adiponectin and interleukin-6 in inflammation-associated disease. Vitam Horm 90: 375–395, 2012.
41. Ma Y, Liu D. Hydrodynamic delivery of adiponectin and adiponectin receptor 2 gene blocks high-fat diet-induced obesity and insulin resistance. Gene Ther 20: 846–852, 2013.
42. Mathis D. Immunological goings-on in visceral adipose tissue. Cell Metab 17: 851–859, 2013.
43. Mirza S, Hossain M, Mathews C, Martinez P, Pino P, Gay JL, Rentfro A, McCormick JB, Fisher-Hoch SP. Type 2-diabetes is associated with elevated levels of TNF-alpha, IL-6 and adiponectin and low levels of leptin in a population of Mexican Americans: a cross-sectional study. Cytokine 57: 136–142, 2012.
44. Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 294: E15– E26, 2008.
45. Nan MH, Park JS, Myung CS. Construction of adiponectin-encoding plasmid DNA and gene therapy of non-obese type 2 diabetes mellitus. J Drug Target 18: 67–77, 2010.
46. Naito M, Fujikura J, Ebihara K, Miyanaga F, Yokoi H, Kusakabe T, Yamamoto Y, Son C, Mukoyama M, Hosoda K, Nakao K. Therapeutic impact of leptin on diabetes, diabetic complications, and longevity in insulin-deficient diabetic mice. Diabetes 60: 2265–2273, 2011.
47. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11: 85–97, 2011.
48. Park S, Kim DS, Kwon DY, Yang HJ. Long-term central infusion of adiponectin improves energy and glucose homeostasis by decreasing fat storage and suppressing hepatic gluconeogenesis without changing food intake. J Neuroendocrinol 23: 687–698, 2011.
49. Pennisi P, Gavrilova O, Setser-Portas J, Jou W, Santopietro S, Clem-mons D, Yakar S, LeRoith D. Recombinant human insulin-like growth factor-I treatment inhibits gluconeogenesis in a transgenic mouse model of type 2 diabetes mellitus. Endocrinology 147: 2619–2630, 2006.
50. Quattrin T, Thrailkill K, Baker L, Litton J, Dwigun K, Rearson M, Poppenheimer M, Giltinan D, Gesundheit N, Martha P Jr. Dual hormonal replacement with insulin and recombinant human insulin like growth factor I in IDDM. Effects on glycemic control, IGF-I levels, and safety profile. Diabetes Care 20: 374–380, 1997.
51. Quattrin T, Thrailkill K, Baker L, Kuntze J, Compton P, Martha P; rhIGF-I in IDDM Study Group. Improvement of HbA1c without increased hypoglycemia in adolescents and young adults with type 1 diabetes mellitus treated with recombinant human insulin-like growth factor-I and insulin. rhIGF-I in IDDM Study Group. J Pediatr Endocrinol Metab 14: 267–277, 2001.
52. Raghow R. Bariatric surgery-mediated weight loss and its metabolic consequences for type-2 diabetes. World J Diabetes 4: 47–50, 2013.
53. Regan FM, Williams RM, McDonald A, Umpleby AM, Acerini CL, O’Rahilly S, Hovorka R, Semple RK, Dunger DB. Treatment with recombinant human insulin-like growth factor (rhIGF)-I/rhIGF binding protein-3 complex improves metabolic control in subjects with severe insulin resistance. J Clin Endocrinol Metab 95: 2113-2122, 2010.
54. Ren J, Anversa P. The insulin-like growth factor I system: physiological and pathophysiological implication in cardiovascular diseases associated with metabolic syndrome. Biochem Pharmacol 93: 409-417, 2010.
55. Rolland C, Hession M, Broom I. Effect of weight loss on adipokine levels in obese patients. Diabetes Metab Syndr Obes 4: 315-323, 2011.
56. Roman S, Agil A, Peran M, Alvaro-Galue E, Ruiz-Ojeda FJ, Fernández-Vázquez G, Marchal JA. Brown adipose tissue and novel therapeutic approaches to treat metabolic disorders. Transl Res 165: 464–479, 2015.
57. Santos J, Salgado P, Santos C, Mendes P, Saavedra J, Baldaque P, Monteiro L, Costa E. Effect of bariatric surgery on weight loss, inflammation, iron metabolism, and lipid profile. Scand J Surg 103: 21-25, 2014.
58. Schneck AS, Iannelli A, Patouraux S, Rousseau D, Bonnafous S, Bailly-Maitre B, Le Thuc O, Rovere C, Panaia-Ferrari P, Anty R, Tran A, Gual P, Gugenheim J. Effects of sleeve gastrectomy in high fat diet-induced obese mice: respective role of reduced caloric intake, white adipose tissue inflammation and changes in adipose tissue and ectopic fat depots. Surg Endosc 28: 592-602, 2014.
59. Sacca L, Orofino G, Petrone A, Vigorito C. Differential roles of splanchnic and peripheral tissues in the pathogenesis of impaired glucose tolerance. J Clin Invest 73: 1683-1687, 1984.
60. Shelbaya S, Amer H, Seddik S, Allah AA, Sabry IM, Mohamed T, El Mosely M. Study of the role of interleukin-6 and highly sensitive C-re-active protein in diabetic nephropathy in type 1 diabetic patients. Eur Rev Med Pharmacol Sci 16: 176-182, 2012.
61. Skarulis MC, Celi FS, Mueller E, Zemskova M, Malek R, Hugen-dubler L, Cochran C, Solomon J, Chen C, Gorden P. Thyroid hormone induced brown adipose tissue and amelioration of diabetes in a patient with extreme insulin resistance. J Clin Endocrinol Metab 95: 256-262, 2010.
62. Stanford KI, Middelbeek RJ, Townsend KL, An D, Nygaard EB, Hitchcox KM, Markan KR, Nakano K, Hirshman MF, Tseng YH, Goodyear LJ. Brown adipose tissue regulates glucose homeostasis and insulin sensitivity. J Clin Invest 123: 215-223, 2013.
63. Tao C, Sifuentes A, Holland WL. Regulation of glucose and lipid homeostasis by adiponectin: effects on hepatocytes, pancreatic fj cells and adipocytes. Best Pract Res Clin Endocrinol Metab 28: 43-58, 2014.
64. Taube A, Schlich R, Sell H, Eckardt K, Eckel J. Inflammation and metabolic dysfunction: links to cardiovascular diseases. Am J Physiol Heart Circ Physiol 302: H2148-H2165, 2012.
65. Thrailkill KM, Quattrin T, Baker L, Kuntze JE, Compton PG, Martha PM. Cotherapy with recombinant human insulin-like growth factor I and insulin improves glycemic control in type 1 diabetes. RhIGF-I in IDDM Study Group. Diabetes Care 22: 585-592, 1999.
66. Vivar R, Humeres C, Varela M, Ayala P, Guzmán N, Olmedo I, Catalán M, Boza P, Muñoz C, Díaz Araya G. Cardiac fibroblast death by ischemia/reperfusion is partially inhibited by IGF-1 through both PI3K/Akt and MEK-ERK pathways. Exp Mol Pathol 93: 1-7, 2012.
67. Viardot A, Lord RV, Samaras K. The effects of weight loss and gastric banding on the innate and adaptive immune system in type 2 diabetes and prediabetes. J Clin Endocrinol Metab 95: 2845-2850, 2010.
68. Wanders D, Graff EC, White BD, Judd RL. Niacin increases adiponec-tin and decreases adipose tissue inflammation in high fat diet-fed mice. PLoS One 8: e71285, 2013.
69. Wang MY, Chen L, Clark GO, Lee Y, Stevens RD, Ilkayeva OR, Wenner BR, Bain JR, Charron MJ, Newgard CB, Unger RH. Leptin therapy in insulin-deficient type I diabetes. Proc Natl Acad Sci USA 107: 4813-4819, 2010.
70. Wang XQ, Lee S, Wilson H, Seeger M, Iordanov H, Gatla N, Whit-tington A, Bach D, Lu JY, Paller AS. Ganglioside GM3 depletion reverses impaired wound healing in diabetic mice by activating IGF-1 and insulin receptors. J Invest Dermatol 134: 1446-1455, 2013.
71. Wu C, Cheng W, Sun Y, Dang Y, Gong F, Zhu H, Li N, Li F, Zhu Z. Activating brown adipose tissue for weight loss and lowering of blood glucose levels: a microPET study using obese and diabetic model mice. PLoS One 9: e113742, 2014.
72. Yang B, Zhou L, Peng B, Sun Z, Dai Y, Zheng J. In vitro comparative evaluation of recombinant growth factors for tissue engineering of bladder in patients with neurogenic bladder. J Surg Res 186: 63-72, 2014.
73. Yin D, Tao J, Lee DD, Shen J, Hara M, Lopez J, Kuznetsov A, Philipson LH, Chong AS. Recovery of islet beta-cell function in strep-tozotocin- induced diabetic mice: an indirect role for the spleen. Diabetes 55: 3256-3263, 2006.
74. Yu X, Park BH, Wang MY, Wang ZV, Unger RH. Making insulin-deficient type 1 diabetic rodents thrive without insulin. Proc Natl Acad Sci USA 105: 14070-14075, 2008.
75. Yu X, Xing C, Pan Y, Ma H, Zhang J, Li W. IGF-1 alleviates ox-LDL-induced inflammation via reducing HMGB1 release in HAECs. Acta Biochim Biophys Sin (Shanghai) 44: 746-751, 2012.
76. Zafrir B. Brown adipose tissue: research milestones of a potential player in human energy balance and obesity. Horm Metab Res 45: 774-785, 2013.
77. Zhang L, Chen Y, Li C, Lin X, Cheng X, Li T. Protective effects of combined intervention with adenovirus vector mediated IL-10 and IGF-1 genes on endogenous islet fj cells in nonobese diabetes mice with onset of type 1 diabetes mellitus. PLoS One 9: e92616, 2014.
78. Zhang H, Wang Y, Zhang J, Potter BJ, Sowers JR, Zhang C. Bariatric surgery reduces visceral adipose inflammation and improves endothelial function in type 2 diabetic mice. Arterioscler Thromb Vasc Biol 31: 2063-2069, 2011.
79. Zhang CC, Zhou JS, Hu JG, Wang X, Zhou XS, Sun BA, Shao C, Lin Q. Effects of IGF-1 on IL-1fj-inducedapoptosis in rabbit nucleus pulposus cells in vitro. Mol Med Rep 7: 441-444, 2103.
80. Zhao P, Deng Y, Gu P, Wang Y, Zhou H, Hu Y, Chen P, Fan X. Insulin-like growth factor 1 promotes the proliferation and adipogenesis of orbital adipose-derived stromal cells in thyroid-associated ophthalmopathy. Exp Eye Res 107: 65-73, 2013.
81. Zhu Z, Spicer EG, Gavini CK, Goudjo-Ako AJ, Novak CM, Shi H. Enhanced sympathetic activity in mice with brown adipose tissue transplantation (transBATation). Physiol Behav 125C: 21-29, 2013.
82. Zoidis E, Ghirlanda-Keller C, Schmid C. Stimulation of glucose transport in osteoblastic cells by parathyroid hormone and insulin-like growth factor I. Mol Cell Biochem 348: 33–42, 2011.